Literature DB >> 8859258

Impaired response to furosemide in hyperprostaglandin E syndrome: evidence for a tubular defect in the loop of Henle.

A Köckerling1, S C Reinalter, H W Seyberth.   

Abstract

In hyperprostaglandin E syndrome (HPS) renal wasting of electrolytes and water is consistently associated with enhanced synthesis of prostaglandin E2. In contrast to Bartter or Gitelman syndrome (BS/GS), HPS is characterized by its severe prenatal manifestation, leading to fetal polyuria, development of polyhydramnios, and premature birth. This disorder mimics furosemide treatment with hypokalemic alkalosis, hypochloremia, isosthenuria, and impaired renal conservation of both calcium and magnesium. Therefore the thick ascending limb of the loop of Henle seems to be involved in HPS. To characterize the tubular defect we investigated the response to furosemide (2 mg/kg) in HPS (n = 8) and BS/GS (n = 3) 1 week after discontinuation of long-term indomethacin treatment. Sensitivity to furosemide was completely maintained in patients with BS/GS. The diuretic, saluretic, and hormonal responses were similar to those of a control group of healthy children (n = 13), indicating an intact function of the thick ascending limb of the loop of Henle in BS/GS. In contrast, patients with HPS had a marked resistance to this loop diuretic. Furosemide treatment increased urine output by 7.5 +/- 0.7 ml/kg per hour in healthy control subjects but only by 4.4 +/- 1.2 ml/kg per hour (p < 0.5) in children with HPS. In parallel, the latter also had a markedly impaired saluretic response (delta Cl(urine) 0.14 +/- 0.04 mmol/kg per hour vs 0.85 +/- 0.09 mmol/kg per hour, p < 0.001; delta Na(urine) 0.23 +/- 0.06 mmol/kg per hour vs 0.77 +/- 0.09 mmol/kg per hour, p < 0.001). Furosemide therapy further enhanced prostaglandin E2 excretion in patients with HPS (54 +/- 17 to 107 +/- 28 ng/hr per 1.73 m2, p < 0.05), whereas no significant effect was observed in healthy children (20 +/- 3 to 12 +/- 3 ng/hr per 1.73 m2). We conclude that a defect of electrolyte reabsorption in the thick ascending limb of the loop of Henle plays a major role in HPS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8859258     DOI: 10.1016/s0022-3476(96)70116-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  7 in total

1.  Diagnosis of a case of Gitelman's syndrome based on renal clearance studies and gene analysis of a novel mutation of the thiazide-sensitive Na-Cl cotransporter.

Authors:  K Kageyama; K Terui; M Shoji; S Tsutaya; E Matsuda; S Sakihara; T Nigawara; T Moriyama; M Yasujima; T Suda
Journal:  J Endocrinol Invest       Date:  2005-10       Impact factor: 4.256

2.  Novel molecular variants of the Na-K-2Cl cotransporter gene are responsible for antenatal Bartter syndrome.

Authors:  R Vargas-Poussou; D Feldmann; M Vollmer; M Konrad; L Kelly; L P van den Heuvel; L Tebourbi; M Brandis; L Karolyi; S C Hebert; H H Lemmink; G Deschênes; F Hildebrandt; H W Seyberth; L M Guay-Woodford; N V Knoers; C Antignac
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

Review 3.  Pathophysiology and clinical presentations of salt-losing tubulopathies.

Authors:  Hannsjörg W Seyberth
Journal:  Pediatr Nephrol       Date:  2015-07-16       Impact factor: 3.714

4.  Linkage of infantile Bartter syndrome with sensorineural deafness to chromosome 1p.

Authors:  T M Brennan; D Landau; H Shalev; F Lamb; B C Schutte; R Y Walder; A L Mark; R Carmi; V C Sheffield
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

5.  Familial hypomagnesemia with hypercalciuria and nephrocalcinosis associated with CLDN16 mutations.

Authors:  Ju Hyung Kang; Hyun Jin Choi; Hee Yeon Cho; Joo Hoon Lee; Il Soo Ha; Hae Il Cheong; Yong Choi
Journal:  Pediatr Nephrol       Date:  2005-07-27       Impact factor: 3.714

6.  Cisplatin Therapy Does Not Worsen Renal Function in Severe Antenatal Bartter Syndrome.

Authors:  Thomas R Welch; David R Shaffer; Darren R Feldman
Journal:  Case Rep Nephrol Dial       Date:  2017-05-08

7.  Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis (FHHNC): compound heterozygous mutation in the claudin 16 (CLDN16) gene.

Authors:  Geeta Hampson; Martin A Konrad; John Scoble
Journal:  BMC Nephrol       Date:  2008-09-24       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.